| Literature DB >> 28231648 |
Hee-June Kim1, Hyun-Joo Lee1, Jong-Chul Lee1, Seung-Gi Min1, Hee-Soo Kyung1.
Abstract
PURPOSE: We encountered 7 cases (7.1%) of infection (5 deep and 2 superficial) in 98 cases of anterior cruciate ligament (ACL) reconstruction using hamstring autografts in a 17-month period. The aim of this study was to analyze the causes of infection and to introduce our treatment strategy.Entities:
Keywords: Anterior cruciate ligament; Infection; Knee; Reconstruction
Year: 2017 PMID: 28231648 PMCID: PMC5336377 DOI: 10.5792/ksrr.16.019
Source DB: PubMed Journal: Knee Surg Relat Res ISSN: 2234-0726
Fig. 1An 18-year-old male patient had a twisting injury during a kicking activity. (A) Magnetic resonance imaging showed a tear of the anterior cruciate ligament (ACL) substances. (B) Arthroscopic examination also revealed a tear of the ACL substances. (C) Double bundle ACL reconstruction using a quadrupled semitendinosus tendon and a doubled gracilis tendon was performed.
Characteristics of the Patients Who Developed Infection after Anterior Cruciate Ligament (ACL) Reconstruction
| Patients | Age (yr) | Sex | Graft | Bundle | Femoral fixation | Tibial fixation |
|---|---|---|---|---|---|---|
| 1 | 44 | Male | Autologous HT | Single | PINN-ACL CrossPin+BS | PT+BS |
| 2 | 18 | Male | Autologous HT | Double | PINN-ACL CrossPin+BS, EndoButton | PT+BS |
| 3 | 40 | Male | Autologous HT | Single | PINN-ACL CrossPin+BS | PT+BS |
| 4 | 34 | Male | Autologous HT | Single | PINN-ACL CrossPin+BS | PT+BS |
| 5 | 19 | Male | Autologous HT | Single | PINN-ACL CrossPin+BS | PT+BS |
| 6 | 24 | Female | Autologous HT | Single | PINN-ACL CrossPin+BS | PT+BS |
| 7 | 16 | Male | Autologous HT | Single | EndoButton | PT+BS |
HT: hamstring tendon, BS: bioabsorbable screw, PT: post-tie.
Characteristics and Findings in 7 Cases of Infection after Anterior Cruciate Ligament Reconstruction
| Patients | Infection type | Time to presentation (days after operation) | Time to surgery (days after symptom) | WBC (103/μL) | ESR (mm/h) | CRP (mg/dL) | Order of surgery | Previous knee surgery |
|---|---|---|---|---|---|---|---|---|
| 1 | Deep joint infection | 15 | 6 | 9.52 | 66 | 21.4 | 4/4 | Yes |
| 2 | Deep joint infection | 7 | 7 | 7.04 | 72 | 19.1 | 4/4 | No |
| 3 | Deep joint infection | 10 | 5 | 8.46 | 28 | 6.7 | 2/3 | No |
| 4 | Deep joint infection | 30 | 1 | 7.79 | 85 | 14.5 | 3/4 | No |
| 5 | Superficial infection | 10 | 7 | 12.03 | 28 | 4.0 | 3/4 | No |
| 6 | Deep joint infection | 11 | 2 | 10.49 | 45 | 0.9 | 3/4 | No |
| 7 | Superficial infection | 89 | 1 | 4.42 | 15 | 0.3 | 4/4 | No |
WBC: peripheral white blood cell count, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
Fig. 2Seven days after anterior cruciate ligament (ACL) reconstruction, the patient had knee pain with fever and chills. Seven days after symptom development, the patient visited the outpatient clinic and arthroscopic debridement was performed. However, methicillin-resistant Staphylococcus aureus infection persisted despite treatment. (A) Therefore, 29 days after the ACL reconstruction, arthroscopic debridement was performed again with removal of the graft and hardware. (B) After infection control, revision ACL reconstruction with bone-patellar tendon-bone allograft was performed. At the 26-month follow-up, the patient recovered nearly all activity and motion, and instability was not evaluated.
Treatment of Infection and Results
| Patients | Organism | Definitive antibiotics | Intravenous antibiotics duration (day) | Operative treatment | No. of procedures for infection | F/U period (mo) | ROM (°) | Tegner activity score | IKDC score | Lysholm score |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MRCNS | Teicoplanin, ciprofloxacin | 20 | AD | 1 | 12 | 125 | 6 | 88.5 | 93 |
| 2 | MRSA | Vancomycin, ciprofloxacin | 26 | AD & graft removal+ACL revision reconstruction | 2 | 26 | 130 | 6 | 88.5 | 94 |
| 3 | MRCNS | Vancomycin, cefazolin | 45 | AD | 1 | 12 | 120 | 7 | 90.8 | 95 |
| 4 | MRCNS | Teicoplanin, ciprofloxacin | 19 | AD | 1 | 12 | 135 | 5 | 79.3 | 88 |
| 5 | EF | Ampicillin, sulbactam | 28 | OD | 3 | 36 | 135 | 7 | 96.6 | 96 |
| 6 | MRCNS+SE | Vancomycin, ciprofloxacin | 38 | AD | 1 | 26 | 130 | 7 | 87.4 | 90 |
| 7 | No growth | Cefazolin | 30 | OD | 2 | 50 | 130 | 6 | 88.5 | 90 |
| Average | 29.4 | 24.9 | 129.3 | 6.3 | 88.5 | 92.3 |
F/U: follow-up, ROM: range of motion, IKDC: International Knee Documentation Committee, MRCNS: methicillin-resistant coagulase-negative Staphylococcus, AD: arthroscopic debridement, MRSA: methicillin-resistant Staphylococcus aureus, ACL: anterior cruciate ligament, EF: Enterococcus faecalis, OD: open debridement, SE: Staphylococcus epidermidis.